期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

基质金属蛋白酶-9基因-1562C/T多态性与过敏性紫癜并发症的关系

下载PDF
导出
摘要 过敏性紫癜（henoch-schoenlein purpura,HSP）是一种临床表现为特征性皮疹、关节疼痛、腹痛、便血、血尿、蛋白尿等症状的小血管炎综合征,其发病机制与免疫和遗传有关。HSP急性期血中炎症细胞因子能上调基质金属蛋白酶（MMP）表达。
作者 方全中 郭爱红 丁振尧 杨娇娇
机构地区 浙江省苍南县人民医院儿科
出处 《浙江中西医结合杂志》 2016年第5期434-435,F0003,共3页 Zhejiang Journal of Integrated Traditional Chinese and Western Medicine
基金 浙江省温州市科技计划项目(No.Y20140252)
关键词 过敏性紫癜 基质金属蛋白酶-9 基因多态性 并发症
分类号 R725.5 [医药卫生—儿科]
  • 相关文献

参考文献9

  • 1Danilewicz M,Wagrowska-Danilewicz M.Differential glome- rular immunoexpression of matrix metalloproteinases MMP- 2 and MMP-9 in idiopathic IgA nephropathy and Schoen- lein-Henoch nephritis[J].Folia Histoehem Cytobiol,2010, 48(1):63-67.
  • 2Raffetto JD,Khalil RA.Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease [J]. Biochem Pharmacol, 2008,75 (2) : 346-359.
  • 3Zou CC,Zhao ZY,Tang LF,et al.Plasma levels of matrix metalloproteinase-9 in Henoch-Schonlein purpura [J]. ScandJ Rheumatol, 2006,35( 1 ) : 52-55.
  • 4Xu J,Zhu D,Sonoda S,et al.Over-expression of BMP4 in- hibits experimental choroidal neovascularization by modu- lating VEGF and MMP-9 [ J ].Angiogenesis, 2012,15 ( 2 ) : 213-227. 2005 : 456.
  • 5Chiang IT, Liu YC, Wang WH, et al.Sorafenib inhibits TPA- induced MMP-9 and VEGF expression via suppression of ERK/NF-KB pathway in hepatocellular carcinoma cells [ J]. In Vivo,2012,26(4) :671-681.
  • 6Xu HM,Zhao Y,Zhang XM,et al.Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins[J].J Surg Res, 2011,168( 1 ) :e143-148.
  • 7Ye S.Polymorphism in matrix metalloproteinase gene promot- ers:implication in regulation of gene expression and suscep- tibility of various diseases [ J ].Matrix Biology, 2000, 19 : 623-629.
  • 8胡亚美,江载芬.诸福棠实用儿科学[M].北京:人民卫生出版社,2005.
  • 9张园海,李丰,徐强,吴蓉洲,项如莲,陈其.基质金属蛋白酶-9基因-1562C/T多态性与川崎病冠脉损害及丙种球蛋白耐药的关系[J].医学研究杂志,2013,42(4):136-139. 被引量：5

二级参考文献11

  • 1Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 201M A- merican Heart Association recommendations for treatment of Kawasaki disease [ J ]. Pediatrics, 2010,125 (2) : e234 - e241.
  • 2Kim HK, Oh J, Hong YM, Sohn S. Parameters to guide retreatment after initial intravenous immunoglohulin therapy in kawasaki disease [J]. Korean Circ J,2011,41 (7) :379 -384.
  • 3Xu J, Zhu D, Sonoda S, et al. Over - expression of BMP4 inhibits ex- perimental choroidal neovaseularization by modulating VEGF and MMP-9[J].Angiogenesis, 2012,15(2) :213 -227.
  • 4Chiang IT, Liu YC, Wang WH, et al. Sorafenib inhibits TPA - in- duced MMP-9 and VEGF expression via suppression of ERK/NF- KB pathway in hepatocellular carcinoma cells [ J ]. In Vivo, 2012,26 (4) :671 -68l.
  • 5Xu HM, Zhao Y, Zhang XM, et al. Polymorphisms in MMP - 9 and TIMP- 2 in Chinese patients with varicose veins[ J]. J Surg Res, 2011,168 ( 1 ) :e143 - e148.
  • 6Vijayalakshmi D, Dhandapani R, Jayaveni S, et al. In vitro anti in- flammatory activity of Aloe vera by down regulation of MMP - 9 in pe- ripheral blood mononuclear cells [ J]. J Ethnopharmacol, 2012, 141 ( 1 ) :542 - 546.
  • 7Park JA, Shin KS, Kim YW. Polymorphism of matrix mctalloprotein- ase - 3 promoter gent as a risk factor for coronary artery lesions in Ka- wasaki disease[J]. J Korean Med Sci,2005,20(4) :607 -611.
  • 8Weng KP, Hsieh KS, Ho TY, et al. IL - 1B polymorphism in associ- ation with initial intravenous immunoglobulin treatment failure in Tai- wanese children with Kawasaki disease[ J]. Cire J,2010,74 ( 3 ) :544 - 551.
  • 9Onouchi Y, Ozaki K, Buns JC, et al. Common variants in CASP3 confer susceptibility to Kawasaki disease [ J ]. Hum Mol Genet,2010, 19(14) :2898 -2906.
  • 10魏洪平,吴敏,朱红枫.川崎病易感基因研究进展[J].实用儿科临床杂志,2008,23(9):705-707. 被引量：13

共引文献116

浙江中西医结合杂志
2016年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部